Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-136"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fi"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-136"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-1372
lpv:speaker	lp:Hannu Takkula2
lpv:spokenAs	member; CULT (2009-07-16--2012-01-18)3 substitute; Delegation for relations with Australia and New Zealand (2009-09-16--2012-02-12)3 unknown; Suomen Keskusta (2009-07-14--2014-06-30)3 substitute; ITRE (2009-07-16--2012-01-18)3 member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2009-09-16--2014-06-30)3 member; ALDE (2009-07-14--2014-06-30)3 member; Delegation for relations with Israel (2009-09-16--2014-06-30)3
lpv:translated text	"Mr President, firstly, I wish to thank Mr Fjellner for an excellent report. It has to be said that it really is important to amend the existing legislation and bring it up to date. If we are talking specifically about medicines and researched data on what the drugs contain, it is also very important for patient safety. Now that advertising has assumed an even greater role, it is essential that we determine the criteria that enable consumers and patients to be fully aware of, and certain about, what sort of effects these medicines have. This information must be based on researched data, and not on fantasy or the ways and means of advertising. Such legislation, which is up­to­date and good for patient safety, is needed more generally in the European Union."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph